PTPRT and cancer: Additionally, researchers have identified tumor neoantigen load (TNB), intratumor heterogeneity, T cell-inflamed gene expression profile (GEP), and mutations in various cancer-related genes (such as TP53, PTPRT, KMT2 family, etc.)as supplementary predictors of ICI response6,7.